Patients Australia chair Michele Robbins said the report demonstrated why the assessment of rare diseases needed to take greater account of the patient, family and societal impact of delayed diagnosis and restricted access to effective treatment.
Rare autoimmune diseases impose a $1.2 billion annual burden on Australians
August 20, 2026 Latest NewsBioPharmaOther Health
Latest Video
New Stories
-
Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence
September 10, 2026 - - Latest News -
Which is it? The two perspectives on patient input compounded by the lack of transparency
September 10, 2026 - - Latest News -
Melbourne oncologist takes the reins at Australia's private cancer physicians body
September 10, 2026 - -
Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this
September 10, 2026 - - Latest News -
Guilt over this enduring failure is the correct response
September 9, 2026 - - Latest News -
Poweroos chase world title in Argentina with new backing from Biogen
September 9, 2026 - - Latest News -
What will AI be capable of in two months? We don't know, and that's the point
September 9, 2026 - - Latest News
